---
figid: PMC5650338__oncotarget-08-74263-g007
figtitle: Annexin A5 suppresses cyclooxygenase-2 expression by downregulating the
  protein kinase C-ζ–nuclear factorKB signaling pathway in prostate cancer cells
organisms:
- Bos taurus
- Oryctolagus cuniculus
- Capra hircus
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Moloney murine leukemia virus
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Drosophila melanogaster
pmcid: PMC5650338
filename: oncotarget-08-74263-g007.jpg
figlink: /pmc/articles/PMC5650338/figure/F7/
number: F7
caption: Scheme for ANXA5 suppressed COX-2 expression via PKC-ζ – NF-κB signaling
  in prostate cancer cells.
papertitle: Annexin A5 suppresses cyclooxygenase-2 expression by downregulating the
  protein kinase C-ζ–nuclear factor-κB signaling pathway in prostate cancer cells.
reftext: Hyoung-Seok Baek, et al. Oncotarget. 2017 Sep 26;8(43):74263-74275.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8793004
figid_alias: PMC5650338__F7
figtype: Figure
redirect_from: /figures/PMC5650338__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5650338__oncotarget-08-74263-g007.html
  '@type': Dataset
  description: Scheme for ANXA5 suppressed COX-2 expression via PKC-ζ – NF-κB signaling
    in prostate cancer cells.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANXA5
  - NFKBIA
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - NFKB1
  - PTGS2
  - EP300
  - CREBBP
  - EIF4E
  - OPN1LW
  - PAG1
  - PCBP4
  - Anxa5
  - Cdc37
  - Lsp1
  - Nfkb1
  - Pold2
  - Cd40
  - Dctn2
  - Rela
  - Gorasp1
  - Ptgs2
  - Crebbp
  - Ep300
  - Pag1
  - Cytip
  - Syt1
  - aPKC
  - Hrb27C
  - betaTub60D
  - Rpt5
  - DCTN2-p50
  - dl
  - wash
  - Dif
  - Rel
  - COX2
  - nej
  - osa
  - CBP
  - eIF4E1
  - Ser
---
